|Bid||6.810 x 0|
|Ask||6.850 x 0|
|Day's Range||6.730 - 6.940|
|52 Week Range||3.410 - 8.580|
|Beta (3Y Monthly)||0.28|
|PE Ratio (TTM)||40.95|
|Forward Dividend & Yield||0.08 (0.74%)|
|1y Target Est||7.48|
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! If you're interested in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349), then you might want to consider it...
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can significantly boost your returns by picking above-average stocks. ToRead More...
Want to participate in a short research study? Help shape the future of investing tools and receive a $60 prize! This article is for investors who would like to improve Read More...
While small-cap stocks, such as Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKG:1349) with its market cap of HK$3.5b, are popular for their explosive growth, investors should also be aware of their Read More...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
A look at the shareholders of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKG:1349) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually Read More...